|
A
|
|---|
| |
Combined cohort
|
|---|
|
Total urine output over 2 hours
|
Sensitivity
|
Specificity
|
|---|
|
≤100 ml
|
90.2%
|
60.0%
|
|
<200 ml
|
87.1%
|
84.1%
|
|
<300 ml
|
85.3%
|
88.0%
|
|
<400 ml
|
66.7%
|
88.0%
|
|
<500 ml
|
50.5%
|
88.0%
|
|
B
Sensitivity and specificity of two hour urine thresholds for progression to AKIN III or death
|
| |
Combined cohort
|
|
Total urine output over two hours
|
Sensitivity
|
Specificity
|
|
<100 ml
|
93.3%
|
53.2%
|
|
<200 ml
|
90%
|
74.2%
|
|
<300 ml
|
87.8%
|
77.4%
|
|
<400 ml
|
66.7%
|
77.4%
|
|
<500 ml
|
53.3%
|
77.4%
|
- The primary outcome was Acute Kidney Injury Network (AKIN) stage III within 14 days of the furosemide stress test.
- The primary outcome was Acute Kidney Injury Network (AKIN) stage III or death within 14 days of the furosemide stress test.
